Arrhythmias Induction and Energy Drinks

  • Keith Andrew Chan


Energy drinks have become a widely popular choice among consumers and are marketed as caffeinated beverages that enhance attention, athletic performance, and short-term cognition. These drinks, with their high-sugar mixtures and additives promising performance-enhancing capabilities packaged in a palatable formula, have seen tremendous growth in the dietary supplement industry, particularly aimed at the young adult population. A recent comprehensive assessment on the impact and growth of the energy drink industry in the United States since 2002 has demonstrated a 500% growth rate over 5 years with such beverages accounting for over half of the functional beverage market in America. However, shortly after their introduction into the market, reports of highly deleterious effects of these beverages on the cardiovascular system including sudden cardiac death swept the media in several high-profile cases, allegedly in connection with consumption of large amounts of energy drinks. This chapter intends to analyze the scientific basis of such claims, to analyze the various components of energy drinks and to determine the preponderance of evidence demonstrating the arrhythmogenic effects of energy drinks.


  1. 1.
    Kumar G, Park S, Onufrak S. Perceptions about energy drinks are associated with energy drink intake among U.S. youth. Am J Health Promot. 2015;29:238–44.CrossRefGoogle Scholar
  2. 2.
    Froiland K, Koszewski W, Hingst J, Kopecky L. Nutritional supplement use among college athletes and their sources of information. Int J Sport Nutr Exerc Metab. 2004;14:104–20.CrossRefGoogle Scholar
  3. 3.
    Heckman MA, Sherry K, De Mejia EG. Energy drinks: an assessment of their market size, consumer demographics, ingredient profile, functionality, and regulations in the United States. Compr Rev Food Sci Food Saf. 2010;9:303–17.CrossRefGoogle Scholar
  4. 4.
    Goldfarb M, Tellier C, Thanassoulis G. Review of published cases of adverse cardiovascular events after ingestion of energy drinks. Am J Cardiol. 2014;113:168–72.CrossRefGoogle Scholar
  5. 5.
    Heneman K, Zidenberg-Cherr S. Nutrition and health info-sheet for health professionals—some facts about energy drinks; Information Pamphlet. Department of Nutrition, University of California; 2007.Google Scholar
  6. 6.
    Clauson KA, Shields KM, McQueen CE, Persad N. Safety issues associated with commercially available energy drinks. J Am Pharm Assoc. 2008;48(3):e55–63.CrossRefGoogle Scholar
  7. 7.
    Finnegan D. The health effects of stimulant drinks. Br Nutr Found Nut Bull. 2003;28:147–55.CrossRefGoogle Scholar
  8. 8.
    Heck CI, de Mejia EG. Yerba mate tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J Food Sci. 2007;72:138–51.CrossRefGoogle Scholar
  9. 9.
    Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72:101–63.CrossRefGoogle Scholar
  10. 10.
    Sved DW, Godsey JL, Ledyard SL, Mahoney AP, Stetson PL, Ho S, Myers NR, Resnis P, Renwick AG. Absorption, tissue distribution, metabolism and elimination of taurine given orally to rats. Amino Acids. 2007;32:459–66.CrossRefGoogle Scholar
  11. 11.
    Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol. 1985;8:276–82.CrossRefGoogle Scholar
  12. 12.
    Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A, et al. Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J. 1986;112:1278–84.CrossRefGoogle Scholar
  13. 13.
    Ohta H, Azuma J, Awata N, Hamaguchi T, Tanaka Y, Sawamura A, et al. Mechanism of the protective action of taurine against isoprenaline induced myocardial damage. Cardiovasc Res. 1988;22:407–13.CrossRefGoogle Scholar
  14. 14.
    Schaffer SW, Shimada K, Jong CJ, Ito T, Azuma J, Takahashi K. Effect of taurine and potential interactions with caffeineon cardiovascular function. Amino Acids. 2014;46(5):1147–57.CrossRefGoogle Scholar
  15. 15.
    Katan MB, Schouten E. Caffeine and arrhythmia. Am J Clin Nutr. 2005;81(3):539–40.CrossRefGoogle Scholar
  16. 16.
    de Andrade F, de Albuquerque CA, Maraschin M, da Silva EL. Safety assessment of yerba mate (Ilex paraguariensis) dried extract: results of acute and 90 days subchronic toxicity studies in rats and rabbits. Food Chem Toxicol. 2012;50(2):328–34.CrossRefGoogle Scholar
  17. 17.
    Lee N-H, Son CG. Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng. J Acupunct Meridian Stud. 2011;4:85–9.CrossRefGoogle Scholar
  18. 18.
    Eby G, Halcomb WW. Elimination of cardiac arrhythmias using oral taurine with l-arginine with case histories: hypothesis for nitric oxide stabilization of the sinus node. Med Hypotheses. 2006;67:1200–4.CrossRefGoogle Scholar
  19. 19.
    Grasser EK, Yepuri G, Dulloo AG, Montani J-P. Cardio- and cerebrovascular responses to the energy drink red bull in young adults: a randomized cross-over study. Eur J Nutr. 2014;53(7):1561–71.CrossRefGoogle Scholar
  20. 20.
    Di Rocco JR, During A, Morelli PJ, Heyden M, Biancaniello TA. Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports. J Med Case Rep. 2011;5:18.CrossRefGoogle Scholar
  21. 21.
    Ward AE, Lipshultz SE, Fisher SD. Energy drink-induced near-fatal ventricular arrhythmia prevented by an intracardiac defibrillator decades after operative “repair” of tetralogy of Fallot. Am J Cardiol. 2014;114:1124–5.CrossRefGoogle Scholar
  22. 22.
    Gray B, Ingles J, Media C, Driscoll T, Semsarian C. Cardiovascular effects of energy drinks in familial long QT syndrome: a randomized cross-over study. Int J Cardiol. 2016;231:148–52.Google Scholar
  23. 23.
    Shen J, Johnson VM, Sullivan LM, Jacques PF, Magnani JW, Lubitz SA, Pandey S, Levy D, Vasan RS, Quatromoni PA, Junyent M, Ordovas JM, Benjamin EJ. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr. 2011;93:261–6.CrossRefGoogle Scholar
  24. 24.
    Conen D, Chiuve SE, Everett BM, Zhang SM, Buring JE, Albert CM. Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr. 2010;92:509–14.CrossRefGoogle Scholar
  25. 25.
    Gordeev IG, Luchinka EE, Pokrovskaya EM. Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study. Cardiovasc Ther Prevent. 2012;11:63–8.Google Scholar
  26. 26.
    Torbey E, Abi Rafeh N, Khoueiry G, Kowalski M, Bekheit S. Ginseng: a potential cause of long QT. J Electrocardiol. 2011;44:357–8.CrossRefGoogle Scholar
  27. 27.
    Zuchinali P, Ribeiro P, Pimentel M, da Rosa P, Zimerman L, Rohde L. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace. 2016;18(2):257–66.CrossRefGoogle Scholar
  28. 28.
    Merrill GF. Experimentally-induced ventricular arrhythmias. Int J Physiol Pathophysiol Pharmacol. 2017;9(6):202–10.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Fletcher E, Lacey C, Aaron M, Kolasa M, Occiano A, Shah S. Randomized controlled trial of high-volume energy drink versus caffeine consumption on ECG and hemodynamic parameters. J Am Heart Assoc. 2017;6(5). pii: e004448.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Keith Andrew Chan
    • 1
  1. 1.Section of Adult CardiologyChong Hua Heart Institute, Chong Hua HospitalCebuPhilippines

Personalised recommendations